But getting an accurate diagnosis (and therefore proper treatment) is extremely hard.

There are very few specialists which creates a huge burden on those physicians, seeing up to 6k patients a year!

The demand for a revolution in epilepsy care is now.It eliminates the long hours needed to comb through patient data and expands treatment for those who don’t have access to EMUs. This is a breakthrough for epilepsy treatment.

Another breakthrough is the EEG data is put through our proprietary seizure prediction algorithm that can signal upcoming seizure events!With SeizureSenz providing prediction data in addition to seizure events, physicians can offer a higher quality of personalized care not currently possible. And it allows critical health care to reach the 80% left behind by today’s process, freeing up physicians and hospital beds to help more patients.

For instance, XLTEK Trek is the most used system but patients have to remain absolutely still during recording with electrodes cemented to their scalp, making it impossible to wear for longer durations to get accurate data.

Our innovations will vastly improve patient diagnosis and thus the lives of the 65M that suffer from this disease.

Quick Path to Revenue

Our customers include neurologists, neurosurgeons, healthcare providers, and healthcare payers. We forecast each physician will need 10 devices/year.

The base cost of SeizureSenz is significantly cheaper than the XLTEK Trek system and massively cheaper than in-hospital monitoring. Customers will also purchase a monthly software subscription.

With a Key Opinion Leader, Dr. James Wheless, on our board, we have immediate market penetration in the Memphis area which consists of 5k patients annually. Expanding to 4 neighboring states states takes us to 500k patients in 2 years.A 30% penetration of the Memphis market gives us a proposed ROI of $27M. As we approach the regional roll-out, a 2% penetration gets us a $90M ROI and we can scale exponentially from there.

Forward looking projections cannot be guaranteed. 

Our Accomplishments So Far

We developed a working prototype, a proprietary algorithm, and were awarded 2 patents (with 2 more to be filed this year).

We received a strong letter of support from a leading neurologist, Dr. Chris Nickele, for our product where he called our innovations “game-changing technology” and “paradigm shifting advantages for EEG.”

The full letter can be downloaded at the bottom of this page. 

The Path Forward

Next steps are to continue to optimize our device design, file for 510(k) regulatory approval, refined reimbursement, and scale our team to optimize our manufacturing and product launch plans.

Vast Pipeline Revolutionary Neurological Monitoring Devices

In addition to SeizureSenz, we are extremely excited about the pipeline of next generation products for other neurological disorders such as traumatic brain injury, sleep apnea, and migraines.

This pipeline will allow us to capture a larger share of the fast-growing EEG market. 

Our innovations will have a major impact on wearable bio-devices, data fusion, neurological data extraction, and visualization of complex biological systems.

Proven Exit Strategy

There are countless examples of similar companies with successful exits. We anticipate possibilities for acquisition as early as 2025 or IPO as early as 2028.

Well-Rounded Team

We have an impressive roster of trusted advisors providing valuable guidance on all aspects of this venture including deep epilepsy expertise, medical sales, the regulatory process, and the launching of healthcare businesses.

The Ask

We are looking to raise $3.5M – $500K on Wefunder – to finalize our product design, achieve regulatory approval, refined reimbursement, and scale up manufacturing and product launch through key hires.

Join us!